PMC:7417114 / 1321-1597
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T4 | 96-98 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T7 | 190-198 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 233-266 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 199-200 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T10 | 207-212 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 63-68 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T11 | 78-94 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
T12 | 96-98 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T14 | 134-144 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
9 | 96-100 | Gene | denotes | IL-6 | Gene:3569 |
17 | 190-198 | Disease | denotes | COVID-19 | MESH:C000657245 |
47 | 207-224 | Species | denotes | human coronavirus | Tax:694448 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 127-144 | http://purl.obolibrary.org/obo/GO_0033673 | denotes | kinase inhibitors |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 147-198 | Sentence | denotes | Clinical need for effective treatments for COVID-19 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T24 | 63-68 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T25 | 78-94 | CHEBI:22587;CHEBI:22587 | denotes | antiviral agents |
T26 | 96-100 | PR:000001393 | denotes | IL-6 |
T27 | 134-144 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T28 | 190-198 | SP_7 | denotes | COVID-19 |
T29 | 207-212 | SP_6;NCBITaxon:9606 | denotes | human |
T30 | 213-224 | NCBITaxon:11118 | denotes | coronavirus |
T31 | 233-245 | SP_7 | denotes | severe acute |
T32 | 246-257 | SP_7;UBERON:0001004 | denotes | respiratory |
T86210 | 63-68 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T21001 | 78-94 | CHEBI:22587;CHEBI:22587 | denotes | antiviral agents |
T50763 | 96-100 | PR:000001393 | denotes | IL-6 |
T21265 | 134-144 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T96695 | 190-198 | SP_7 | denotes | COVID-19 |
T87836 | 207-212 | SP_6;NCBITaxon:9606 | denotes | human |
T86920 | 213-224 | NCBITaxon:11118 | denotes | coronavirus |
T8928 | 233-245 | SP_7 | denotes | severe acute |
T15588 | 246-257 | SP_7;UBERON:0001004 | denotes | respiratory |